PA
CVS icon

Parallel Advisors’s CVS Health CVS Stock Holding History

Parallel Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$896K Buy
12,478
+869
+7% +$66.9K 0.02% 515
2025
Q4 		$921K Buy
11,609
+3,516
+43% +$277K 0.02% 470
2025
Q3 		$610K Sell
8,093
-337
-4% -$23.1K 0.01% 592
2025
Q2 		$581K Sell
8,430
-1,895
-18% -$124K 0.01% 575
2025
Q1 		$699K Buy
10,325
+2,663
+35% +$159K 0.02% 485
2024
Q4 		$344K Sell
7,662
-2,242
-23% -$126K 0.01% 714
2024
Q3 		$623K Sell
9,904
-7,512
-43% -$438K 0.01% 506
2024
Q2 		$1.03M Sell
17,416
-1,236
-7% -$77.3K 0.03% 357
2024
Q1 		$1.49M Sell
18,652
-5,605
-23% -$428K 0.04% 279
2023
Q4 		$1.92M Buy
24,257
+3,732
+18% +$266K 0.06% 210
2023
Q3 		$1.43M Sell
20,525
-1,527
-7% -$108K 0.05% 239
2023
Q2 		$1.52M Sell
22,052
-1,615
-7% -$115K 0.05% 245
2023
Q1 		$1.76M Sell
23,667
-2,834
-11% -$238K 0.06% 219
2022
Q4 		$2.47M Sell
26,501
-2,020
-7% -$195K 0.11% 134
2022
Q3 		$2.72M Buy
28,521
+1,666
+6% +$165K 0.13% 115
2022
Q2 		$2.49M Buy
26,855
+1,098
+4% +$107K 0.11% 125
2022
Q1 		$2.67M Sell
25,757
-14,961
-37% -$1.57M 0.11% 135
2021
Q4 		$4.2M Buy
40,718
+6,196
+18% +$573K 0.16% 105
2021
Q3 		$2.93M Buy
34,522
+4,284
+14% +$359K 0.12% 132
2021
Q2 		$2.52M Buy
30,238
+1,117
+4% +$91.5K 0.11% 140
2021
Q1 		$2.19M Buy
29,121
+4,094
+16% +$298K 0.1% 143
2020
Q4 		$1.71M Sell
25,027
-5,775
-19% -$376K 0.09% 154
2020
Q3 		$1.8M Sell
30,802
-6,184
-17% -$385K 0.11% 141
2020
Q2 		$2.4M Buy
36,986
+17,138
+86% +$1.08M 0.16% 100
2020
Q1 		$1.18M Buy
19,848
+850
+4% +$56.7K 0.1% 144
2019
Q4 		$1.41M Buy
18,998
+1,092
+6% +$76.7K 0.11% 145
2019
Q3 		$1.13M Sell
17,906
-1,210
-6% -$71.7K 0.1% 159
2019
Q2 		$1.04M Buy
19,116
+1,215
+7% +$65.4K 0.1% 147
2019
Q1 		$965K Buy
17,901
+7,810
+77% +$482K 0.11% 144
2018
Q4 		$661K Buy
10,091
+1,571
+18% +$117K 0.09% 160
2018
Q3 		$671K Buy
8,520
+572
+7% +$40.9K 0.08% 173
2018
Q2 		$511K Buy
7,948
+4,000
+101% +$264K 0.07% 181
2018
Q1 		$246K Sell
3,948
-339
-8% -$24.3K 0.04% 283
2017
Q4 		$311K Sell
4,287
-1,203
-22% -$87.5K 0.05% 246
2017
Q3 		$392K Sell
5,490
-2,303
-30% -$182K 0.07% 196
2017
Q2 		$623K Buy
7,793
+562
+8% +$44.4K 0.12% 135
2017
Q1 		$576K Sell
7,231
-509
-7% -$40.6K 0.11% 140
2016
Q4 		$611K Buy
+7,740
New +$626K 0.14% 120

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parallel Advisors's CVS Position: Q1 2026 in Review

Parallel Advisors increased its CVS Health (CVS) stake by 7.5% in Q1 2026, buying an estimated $66.9K and bringing the position to 12,478 shares worth $896K. The position accounts for 0.02% of the portfolio, ranked #515.

Parallel Advisors first reported a position in CVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $4.2M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Parallel Advisors held 12,478 shares of CVS Health worth $896K as of Q1 2026.
  • Parallel Advisors bought 869 CVS Health shares in Q1 2026, an estimated $66.9K.
  • CVS Health made up 0.02% of Parallel Advisors's portfolio in Q1 2026, its #515 holding.
  • Parallel Advisors first reported a position in CVS Health in Q4 2016 and has held it in 38 quarters since.
  • Parallel Advisors's CVS Health position peaked at $4.2M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.